Dr. Zemanick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
13123 E 16th Ave
Aurora, CO 80045Phone+1 720-777-1234Fax+1 720-777-7284
Education & Training
U Colorado2004 - 2008
Children's National HospitalResidency, Pediatrics, 1999 - 2002
Albert Einstein College of MedicineClass of 1999
Certifications & Licensure
CO State Medical License 2004 - 2025
MD State Medical License 2002 - 2005
DC State Medical License 2001 - 2004- American Board of Pediatrics Pediatric Pulmonology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) Start of enrollment: 2011 Apr 01
- PK Study of N91115 in Cystic Fibrosis Patients Start of enrollment: 2014 Oct 01
- Study of Cavosonstat (N91115) in Patients With CF Homozygous for the F508del-CFTR Mutation Start of enrollment: 2015 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Outcomes of prenatal use of elexacaftor/tezacaftor/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis.Angela Metcalf, Stacey L Martiniano, Scott D Sagel, Michael V Zaretsky, Edith T Zemanick
Journal of Cystic Fibrosis. 2024-12-06 - 1 citationsOlfactory loss in people with cystic fibrosis: Community perceptions and impact.Jessa E Miller, Christine M Liu, Edith T Zemanick, Jason C Woods, Christopher H Goss
Journal of Cystic Fibrosis. 2024-11-01 - The Role of the Microbiome in Pediatric Respiratory Diseases.Edith T Zemanick, Christian Rosas-Salazar
Clinics in Chest Medicine. 2024-09-01
Journal Articles
- Changes in Microbiome Diversity Following Beta-Lactam Antibiotic Treatment Are Associated with Therapeutic Versus Subtherapeutic Antibiotic Exposure in Cystic FibrosisGeovanny F Perez, Anastassios C Koumbourlis, Andrea Hahn, Robert J Freishtat, Edith T Zemanick, Hollis Chaney, Nature
- Novel Application of Aptamer Proteomic Analysis in Cystic Fibrosis Bronchoalveolar Lavage FluidScott D Sagel, Robin R Deterding, Emily M DeBoer, Jonathan Popler, Edith T Zemanick, Frank J Accurso, PROTEOMICS – Clinical Applications
- Volatile Molecules from Bronchoalveolar Lavage Fluid Can ‘Rule-In’ Pseudomonas Aeruginosa and ‘Rule-Out’ Staphylococcus Aureus Infections in Cystic Fibrosis PatientsChristiaan A Rees, Edith T Zemanick, Nature
Press Mentions
- Researchers Explore Trikafta in Younger PatientsAugust 25th, 2021
Characterizing Mucociliary Clearance in Young Children with Cystic FibrosisMarch 22nd, 2021
Studying Trikafta for Better Cystic Fibrosis CareJanuary 31st, 2020- Join now to see all
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
